Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yijia Du

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Diabetes Investigation|January 7, 2021
Diagnostic value of dysregulated microribonucleic acids in the placenta and circulating exosomes in gestational diabetes mellitusLei Zhang, Ting Zhang, Daoxu Sun, et al.
Translational Lung Cancer Research|November 14, 2025
Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory studyYijia Du, Yanying Li, Min Yu, et al.
Translational Lung Cancer Research|May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than <i>EGFR</i>: a multicenter real-world analysisTian Tian, Yanying Li, Juan Li, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Diabetes Investigation|January 7, 2021
Diagnostic value of dysregulated microribonucleic acids in the placenta and circulating exosomes in gestational diabetes mellitusLei Zhang, Ting Zhang, Daoxu Sun, et al.
Translational Lung Cancer Research|November 14, 2025
Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory studyYijia Du, Yanying Li, Min Yu, et al.
Translational Lung Cancer Research|May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than <i>EGFR</i>: a multicenter real-world analysisTian Tian, Yanying Li, Juan Li, et al.
Pageof 2